serum samples
HMCs
-
proliferation (promotes); migration (promotes); inflammation (promotes); fibrosis (promotes); ceRNA regulation (promotes); other pathway/process (inhibits)
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; Transfection; CCK8; Wound Healing Assay; ELISA; Western Blot
May represent a novel therapeutic target for DN treatment.
circADAM9 is upregulated in serum samples from diabetic nephropathy patients and in high glucose-treated human mesangial cells. It promotes mesangial cell injury, including proliferation, migration, inflammation, fibrosis, and oxidative stress, by sponging miR-545-3p to activate USP15 and inhibit the Keap1/Nrf2 pathway. The study suggests circADAM9 may be a potential therapeutic target for diabetic nephropathy.
0.7032
Circular RNA circADAM9 Promotes Inflammation, Oxidative Stress, and Fibrosis of Human Mesangial Cells via the Keap1-Nrf2 Pathway in Diabetic Nephropathy.
combined biological and clinical study